Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,832 public trials 5,044 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

NCT06289673

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Our Lady of the Lakes Regional Medical Center Baton Rouge, Louisiana, United States
  • Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States
  • Saint Francis Children's Hospital Tulsa, Oklahoma, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Alabama Neurology Associates PC Birmingham, Alabama, United States
  • Ctr for Neurology and Spine Phoenix, Arizona, United States
  • AZ Integrated Neuro and Spine Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
View all 236 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT05650632

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona /ID# 251405 Phoenix, Arizona, United States
  • Highlands Oncology Group - Springdale /ID# 267742 Springdale, Arkansas, United States
  • Rocky Mountain Cancer Centers - Aurora /ID# 268574 Aurora, Colorado, United States
  • Medical Oncology Hematology Consultants /ID# 268560 Newark, Delaware, United States
View all 46 locations
View Trial Details
Recruiting

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

NCT07302347

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations
  • Nagoya City University Hospital ( Site 0003) Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital ( Site 0007) Nagoya, Aichi-ken, Japan
  • Sapporo Hokuyu Hospital ( Site 0005) Sapporo, Hokkaido, Japan
  • Hyogo Prefectural Kobe Children's Hospital ( Site 0006) Kobe, Hyōgo, Japan
View Trial Details
Recruiting

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

NCT07073547

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Automated Insulin for Management of Intrapartum Glycemia

NCT06883344

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details

Related conditions